- CDK4/6 Inhibitor Strategies in HR+ Breast Cancer: From Early to Frontline Advanced Stages
- Sequencing Strategies in HR+ mBC
- Advances in TNBC and HER2+ Breast Cancer: What’s the latest?
- Real World Oncology: Translating Data to Clinical Practice
- Evolving the Frontline: Navigating Treatment Landscapes Advanced/Recurrent Endometrial Cancer
- Optimal Treatment Selection of PARP Inhibitors in Ovarian Cancer
- Antibody-Drug Conjugates in Ovarian and Cervical Cancers
OncLive® State of the Science Summit™: Women's Health
Country Music Hall of Fame
222 Rep. John Lewis Way S
Nashville, TN 37203
United States
Monday, July 14, 2025
6:00 PM-9:00 PM CDT
Complimentary Parking
In-Person Only
Event Co-Chairs
Erika Hamilton, MD
Sarah Cannon Research Institute (SCRI)
SCRI Oncology Partners
Katy Moore, MD, MS, FASCO
SCRI at Stephenson Cancer Center – University of Oklahoma
IN PARTNERSHIP WITH
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512